RBC Life Sciences Names Veteran Strategic Growth Leader, Robert Kaiser, to the Company's Board of Directors

Kaiser brings more than three decades of executive-level leadership to the board at a time when RBC Life Sciences is focusing on aggressive domestic and international expansion. Comprised of an advanced wound care and pain management products subsidiary and a nutritional supplements subsidiary, RBC Life Sciences grew nearly 25 percent in 2007.

"Robert has an impressive entrepreneurial background and strategic experience in profit and revenue expansion and shareholder development that will serve the company as it positions itself moving forward," said RBC Life Sciences President John Price. "Robert's expertise will be invaluable as we redouble growth efforts within the United States and abroad."

Kaiser is chairman and CEO of CLST Holdings, the public company remaining from the 2007 sale of Cellstar Inc., an international logistics and distribution firm serving the communications industry. As Cellstar's chairman and CEO, Kaiser raised the company's market capitalization by securing new funding sources, developing new product lines and entering new markets.

"RBC Life Sciences has a compelling story of helping people globally improve quality of life," Kaiser said. "Its nutritional supplements subsidiary of the same name offers one of the most-respected array of products in the industry. Meanwhile, its wound care and pain management subsidiary—MPM Medical Inc.—is continuing to gain praise for its one-of-a-kind product offering. I am proud to join RBC's board to help it become the household name that it deserves."

Kaiser previously was CEO of Mobile Star, CEO and CFO of Skytel/Worldcom from 1996 to 2001, CFO of Cingular/Southwestern Bell Mobile Systems from 1986 to 1996 and CFO of LTV Energy from 1976 to 1985.

RBC Life Sciences is a pioneer in the truest definition of the word. The company's founder, CEO Clinton Howard, made history during the early 1980s when he organized a team of scientists to unlock the age-old mystery behind the health-giving properties of the aloe vera plant. For centuries, scribes—everyone from Old Testament authors and

Egyptian pharaohs to Aristotle and Alexander the Great—have sung the praises of the unassuming plant, yet none were able to pinpoint why it was beneficial to health.

Howard's team cracked the code—and entered the annals of medical history—when it isolated the active ingredient, a long-chain polysaccharide found in the inner leaf gel of the plant.

Howard incorporated his findings into many of the nutritional supplements and personal care products offered by RBC Life Sciences. Meanwhile, MPM Medical incorporated the findings into its array of wound care and pain management products. MPM Medical joined RBC Life Sciences in 1991.

About RBC Life Sciences

RBC Life Sciences develops, manufactures and markets high quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at http://www.rbclifesciences.com/.

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

Contacts: